Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets ... Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others. Show more
WESTPORT, Conn., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (โPortageโ or the โCompanyโ) (NASDAQ: PRTG), a clinical-stage immuno-oncology company with a portfolio of novel...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.65 | 16.3727959698 | 3.97 | 5 | 3.8 | 38370 | 4.46191411 | CS |
4 | -1.6 | -25.7234726688 | 6.22 | 7.11 | 3.8 | 41952 | 5.06875127 | CS |
12 | 0.07 | 1.53846153846 | 4.55 | 23.01 | 2.81 | 989300 | 9.53484676 | CS |
26 | -0.38 | -7.6 | 5 | 23.01 | 2.098 | 1277854 | 6.74865919 | CS |
52 | -23.78 | -83.7323943662 | 28.4 | 40.8 | 2.098 | 702100 | 6.95375707 | CS |
156 | -380.58 | -98.800623053 | 385.2 | 407.43 | 2.098 | 251307 | 15.1418103 | CS |
260 | -745.38 | -99.384 | 750 | 899.526 | 2.098 | 208350 | 31.16729599 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.